SEHK:867Pharmaceuticals
Exclusive Novartis Ophthalmology Deal Might Change The Case For Investing In China Medical System Holdings (SEHK:867)
On October 27, 2025, China Medical System Holdings announced that its subsidiary CMS Vision International Management Limited had entered into an exclusive five-year distribution agreement with Novartis Pharma Services AG to import, distribute, sell, and promote Lucentis and Beovu injections in mainland China.
This collaboration expands CMS Vision's ophthalmology portfolio with two key, internationally recognized treatments, strengthening its market presence and offering broader therapeutic...